Catatonia: An open prospective series with carbamazepine

35Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

In view of reports in the literature that catatonia responds well to benzodiazepines, and the possible association between catatonia and seizure disorders, an open prospective study was conducted to explore the possibility that catatonia may be successfully treated with carbamazepine. Patients meeting DSM-IV criteria for catatonia were challenged with lorazepam IMI and their response assessed. Non-responders, partial responders and patients who had a recurrence of symptoms were put on a trial of carbamazepine and their response assessed. Nine patients were assessed at our unit. Six of the 9 had a complete, but transient response to lorazepam. All of the patients were given a trial of carbamazepine: 4 had a complete resolution of catatonic symptoms, 1 had a partial resolution and 4 patients did not show a significant improvement. Carbamazepine seems to be an effective treatment, both in the acute phase, and as maintenance in a subgroup of retarded catatonic patients.

Author supplied keywords

Cite

CITATION STYLE

APA

Kritzinger, P. R., & Jordaan, G. P. (2001). Catatonia: An open prospective series with carbamazepine. International Journal of Neuropsychopharmacology, 4(3), 251–257. https://doi.org/10.1017/S1461145701002486

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free